These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11779181)

  • 1. Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite.
    Ahmed Z; Ravandi A; Maguire GF; Emili A; Draganov D; La Du BN; Kuksis A; Connelly PW
    Biochem Biophys Res Commun; 2002 Jan; 290(1):391-6. PubMed ID: 11779181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.
    Ahmed Z; Ravandi A; Maguire GF; Emili A; Draganov D; La Du BN; Kuksis A; Connelly PW
    J Biol Chem; 2001 Jul; 276(27):24473-81. PubMed ID: 11320081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.
    Connelly PW; Draganov D; Maguire GF
    Free Radic Biol Med; 2005 Jan; 38(2):164-74. PubMed ID: 15607900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine.
    Ahmed Z; Babaei S; Maguire GF; Draganov D; Kuksis A; La Du BN; Connelly PW
    Cardiovasc Res; 2003 Jan; 57(1):225-31. PubMed ID: 12504832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of apolipoprotein AI-phosphatidylcholine core aldehyde Schiff base adducts promotes uptake by THP-1 macrophages.
    Ahmed Z; Ravandi A; Maguire GF; Kuksis A; Connelly PW
    Cardiovasc Res; 2003 Jun; 58(3):712-20. PubMed ID: 12798446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols.
    Nishio E; Watanabe Y
    Biochem Biophys Res Commun; 1997 Jul; 236(2):289-93. PubMed ID: 9240427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrite-mediated inactivation of human plasma paraoxonase-1: possible beneficial effect of aromatic amino acids.
    Abd-Allah GM; Mariee AD
    Appl Biochem Biotechnol; 2008 Sep; 150(3):281-8. PubMed ID: 18682903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice.
    Forte TM; Subbanagounder G; Berliner JA; Blanche PJ; Clermont AO; Jia Z; Oda MN; Krauss RM; Bielicki JK
    J Lipid Res; 2002 Mar; 43(3):477-85. PubMed ID: 11893784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity].
    Josse D; Masson P
    Ann Pharm Fr; 2001 Apr; 59(2):108-18. PubMed ID: 11320335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery of paraoxonase-1 inhibits neointimal hyperplasia after arterial balloon-injury in rabbits fed a high-fat diet.
    Miyoshi M; Nakano Y; Sakaguchi T; Ogi H; Oda N; Suenari K; Kiyotani K; Ozono R; Oshima T; Yoshida T; Chayama K
    Hypertens Res; 2007 Jan; 30(1):85-91. PubMed ID: 17460375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distributions of hydroperoxide positional isomers generated by oxidation of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine in liposomes and in methanol solution.
    Wang XH; Ushio H; Ohshima T
    Lipids; 2003 Jan; 38(1):65-72. PubMed ID: 12669821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of phosphatidylcholine oxidation products in human plasma using quadrupole time-of-flight mass spectrometry.
    Adachi J; Asano M; Yoshioka N; Nushida H; Ueno Y
    Kobe J Med Sci; 2006; 52(5):127-40. PubMed ID: 17006053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of phosphatidylcholine oxidation products in rat heart using quadrupole time-of-flight mass spectrometry.
    Adachi J; Yoshioka N; Sato M; Nakagawa K; Yamamoto Y; Ueno Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):37-43. PubMed ID: 16055051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
    Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
    Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R.
    Aviram M; Billecke S; Sorenson R; Bisgaier C; Newton R; Rosenblat M; Erogul J; Hsu C; Dunlop C; La Du B
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1617-24. PubMed ID: 9763535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.